These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 23809924)

  • 1. Genetic variation and HIV-associated neurologic disease.
    Dahiya S; Irish BP; Nonnemacher MR; Wigdahl B
    Adv Virus Res; 2013; 87():183-240. PubMed ID: 23809924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment.
    Li L; Aiamkitsumrit B; Pirrone V; Nonnemacher MR; Wojno A; Passic S; Flaig K; Kilareski E; Blakey B; Ku J; Parikh N; Shah R; Martin-Garcia J; Moldover B; Servance L; Downie D; Lewis S; Jacobson JM; Kolson D; Wigdahl B
    J Neurovirol; 2011 Feb; 17(1):92-109. PubMed ID: 21225391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia.
    Cowley D; Gray LR; Wesselingh SL; Gorry PR; Churchill MJ
    J Neurovirol; 2011 Feb; 17(1):70-81. PubMed ID: 21165788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia.
    Schnell G; Spudich S; Harrington P; Price RW; Swanstrom R
    PLoS Pathog; 2009 Apr; 5(4):e1000395. PubMed ID: 19390619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function.
    Tilghman MW; Bhattacharya J; Deshpande S; Ghate M; Espitia S; Grant I; Marcotte TD; Smith D; Mehendale S
    J Med Virol; 2014 Jan; 86(1):88-96. PubMed ID: 24150902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat.
    Rappaport J; Joseph J; Croul S; Alexander G; Del Valle L; Amini S; Khalili K
    J Leukoc Biol; 1999 Apr; 65(4):458-65. PubMed ID: 10204574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins.
    Jadhav S; Nema V
    Mediators Inflamm; 2021; 2021():1267041. PubMed ID: 34483726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
    Spudich S; González-Scarano F
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte/macrophages and their role in HIV neuropathogenesis.
    Burdo TH; Lackner A; Williams KC
    Immunol Rev; 2013 Jul; 254(1):102-13. PubMed ID: 23772617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.
    Marino J; Maubert ME; Mele AR; Spector C; Wigdahl B; Nonnemacher MR
    Cell Mol Life Sci; 2020 Dec; 77(24):5079-5099. PubMed ID: 32577796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.
    Sacktor N; Nakasujja N; Skolasky RL; Rezapour M; Robertson K; Musisi S; Katabira E; Ronald A; Clifford DB; Laeyendecker O; Quinn TC
    Clin Infect Dis; 2009 Sep; 49(5):780-6. PubMed ID: 19622045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.
    Evering TH
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):72-83. PubMed ID: 29460224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the roles for Vpr in HIV-1-associated neuropathogenesis.
    James T; Nonnemacher MR; Wigdahl B; Krebs FC
    J Neurovirol; 2016 Aug; 22(4):403-15. PubMed ID: 27056720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia.
    Burdo TH; Nonnemacher M; Irish BP; Choi CH; Krebs FC; Gartner S; Wigdahl B
    DNA Cell Biol; 2004 Apr; 23(4):261-9. PubMed ID: 15142383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
    Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
    J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of genetic diversity and amino acid sequence of HIV-1tat in CNS and peripheral tissue of a patient with ADC and a patient with non-ADC].
    Pu SS; Li YP; Yan YF; Wen HL; Wang ZY; Song YY; Xu HZ; Zhao L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):251-3. PubMed ID: 22097599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia.
    Churchill MJ; Figueiredo A; Cowley D; Gray L; Purcell DF; Sullivan JS; McPhee DA; Wesselingh SL; Brew BJ; Gorry PR
    J Neurovirol; 2006 Jun; 12(3):219-28. PubMed ID: 16877303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
    Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
    J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression.
    Hogan TH; Stauff DL; Krebs FC; Gartner S; Quiterio SJ; Wigdahl B
    J Neurovirol; 2003 Feb; 9(1):55-68. PubMed ID: 12587069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving paradigms in the pathogenesis of HIV-1-associated dementia.
    Fischer-Smith T; Rappaport J
    Expert Rev Mol Med; 2005 Dec; 7(27):1-26. PubMed ID: 16321172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.